A new study provides further evidence that people with certain blood types may be more likely to contract COVID-19. Specifically, it found that the new coronavirus (SARS-CoV-2) is particularly attracted to the blood group A antigen found on respiratory cells. The researchers focused on a protein on the surface of the SARS-CoV-2 virus called the… read on > read on >
College students with attention-deficit/hyperactivity disorder (ADHD) have a harder time making it to graduation than their peers do, a new study suggests. Researchers found that of 400 students they followed, those with ADHD had a lower grade-point average (GPA) — about half a grade lower — than students without the disorder. The gap emerged freshman… read on > read on >
WEDNESDAY, March 3, 2021 (American Heart Association News) — Stuck in traffic, with a nasty storm making a stressful commute even worse, Joanne Loewy reached for the car radio. “I felt my heartbeat rise,” said Loewy, director of the Louis Armstrong Center for Music and Medicine at Mount Sinai Beth Israel in New York City.… read on > read on >
(Healthday News) — The United States is now poised to have enough COVID-19 vaccines for every American adult by the end of May, President Joe Biden said Tuesday. The announcement, which came during a brief speech at the White House, accelerates the country’s vaccination goals by two months. “As a consequence of the stepped-up process… read on > read on >
Ever been caught in small-talk you secretly wanted to end? So has nearly everyone else, according to new research that finds that both partners in a conversation often want it to end sooner than it does. The flip side is often true, as well. Study author Adam Mastroianni said that his team was “surprised to… read on > read on >
Doctors are testing a decades-old surgical technique as a new way to treat certain stroke patients. And the preliminary results look promising, they say. At issue are strokes caused by intracranial atherosclerosis, where blood vessels within the brain become hardened and narrowed. Strokes occur when the blood supply to the brain is disrupted, depriving tissue… read on > read on >
A clinical trial evaluating the use of convalescent plasma in patients with mild to moderate COVID-19 symptoms has been halted because the treatment didn’t benefit them, according to the U.S. National Institutes of Health. Convalescent plasma (also called “survivor’s plasma”) is derived from the blood of patients who have already recovered from COVID-19. It’s thought… read on > read on >
Wider use of prescription generic drugs could save Medicare nearly $2 billion a year, researchers say. The new analysis of Medicare Part D prescription drug claims for 2017 used a random 20% of beneficiaries, 224 drugs with one or more generic substitutes and at least 1,000 claims. Medicare Part D accounts for roughly one-third of… read on > read on >
Two new studies suggest that the jury is still out on whether the arthritis drug tocilizumab helps those with severe COVID-19. Both reports were published recently in the New England Journal of Medicine. The first, from scientists at the University of California, San Diego, found tocilizumab didn’t improve outcomes or reduce the risk of death… read on > read on >
People with kidney failure related to sickle cell disease are less likely to receive a transplant than those without sickle cell disease, but it could be life-saving for them, a new study finds. Sickle cell disease is a risk factor for kidney failure, and adults with sickle cell-related kidney failure who are on long-term dialysis… read on > read on >
